Collectively, these results further suggest that TRIM29 can inhibit phosphorylation of β-catenin and subsequently enhance β-catenin level through leading to phosphorylation of GSK3β, thus promoting nuclear accumulation of β-catenin and the expression of the Wnt/β-catenin target genes in colorectal cancer. The gene discussed is TRIM29; the disease is colorectal cancer.